Back
Brookfield Infrastructure Partners LP Vs. Blueprint Medicines Industry Stock Comparison
Buy
61
BIP
Brookfield Infrastructure Partners LP
Last Price:
$33.99
Seasonality Move:
3.83%
Sell
49
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
6.28%
Buy
61
Brookfield Infrastructure Partners LP (BIP)
is a Buy
Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?
-
The current Brookfield Infrastructure Partners LP [BIP] share price is $33.79. The Score for BIP is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
BIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.20. The Score for BPMC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIP Stock Price Chart
What is Brookfield Infrastructure Partners LP's stock price today?
-
The Brookfield Infrastructure Partners LP share price today is $33.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIP is experiencing slight buying pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
BIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 61.4 | Buy |
Chaikin Money Flow: | 110732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.94 - 33.64) | Buy |
Bollinger Bands (100): | (29.17 - 33.29) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.95 | Buy |
Relative Strength Index (14 RSI): | 74.28 | Buy |
Chaikin Money Flow: | -2317947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (115.48 - 133.94) | Buy |
Bollinger Bands (100): | (84.59 - 116.61) | Buy |
BIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.4 | Buy |
20-day SMA: | 33.31 | Buy |
50-day SMA: | 32.26 | Buy |
200-day SMA: | 32.41 | Buy |
8-day EMA: | 33.47 | Buy |
20-day EMA: | 33.21 | Buy |
50-day EMA: | 32.44 | Buy |
200-day EMA: | 31.75 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.24 | Sell |
20-day SMA: | 128.13 | Buy |
50-day SMA: | 110.68 | Buy |
200-day SMA: | 97.39 | Buy |
8-day EMA: | 128.1 | Buy |
20-day EMA: | 124.9 | Buy |
50-day EMA: | 114.53 | Buy |
200-day EMA: | 100.49 | Buy |
Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.72 per share, and an increase next year of $0.20 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Brookfield Infrastructure Partners LP Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |